Our analysis identified eight potential biomarkers of HNSCC recurrence, namely PROS1, ANXA3, COL2A1, F3, TUBB3, PSMB5, SLC7A11/xCT, and CD2 (Fig. 7a). This evidence concerns the gene COL2A1 and head and neck squamous cell carcinoma.